Rivastigmine

A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.

Year introduced: 2016 (1992)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): D02.241.081.251.583.899

MeSH Unique ID: D000068836

Registry Number: PKI06M3IW0

Entry Terms:

• (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
• Exelon
• RivastigmineTartrate
• Rivastigmine Hydrogen Tartrate
• Hydrogen Tartrate, Rivastigmine
• Tartrate, Rivastigmine Hydrogen
• ENA 713
• 713, ENA
• ENA-713
• ENA713
• SDZ ENA 713
• 713, SDZ ENA
• ENA 713, SDZ

Pharmacologic Action:

• Cholinesterase Inhibitors
• Neuroprotective Agents

All MeSH Categories
Chemicals and Drugs Category
Organic Chemicals
Carboxylic Acids
Acids, Acyclic
Carbamates
Phenylcarbamates
Rivastigmine